¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
7/23 ¹ßÇ¥³í¹® ÀÔ´Ï´Ù
ÀÛ¼ºÀÏ
2022-07-21
Á¶È¸¼ö
234


¾È³çÇϼ¼¿ä. À̹øÁÖ ¹ßÇ¥ÀÚ ¿µÁø ÀÔ´Ï´Ù.

Á¦°¡ À̹øÁÖ Åä¿äÀÏ¿¡ ¹ßÇ¥ ÇÒ ³í¹®Àº ¿ÃÇØ JEM¿¡ ÃâÆǵÈ
Angiotensin II enhances group 2 innate lymphoid cell responses via AT1a during airway inflammation " ÀÔ´Ï´Ù.


ILC2´Âairway inflammationÀ» À¯¹ßÇÏ´Â Áß¿äÇÑ ¸é¿ª¼¼Æ÷ Áß Çϳª·Î ÃÖ±Ù¿¡ ÁÖ¸ñ¹Þ°í ÀÖÀ¸¸ç, °ü·Ã ¿¬±¸´Â Áõ°¡ÇÏ°í ÀÖ½À´Ï´Ù.
Asthma »óȲ ½Ã lung epithelial cell¿¡¼­ ºÐºñµÇ´Â È¿¼ÒµéÀÇ ÀÛ¿ëÀ¸·Î ÀÎÇØ Angiotensin II (Ang II)ÀÇ ºÐºñ°¡ Áõ°¡µÊÀ» È®ÀÎÇÏ¿´À¸¸ç,
Ang II´Â ILC2ÀÇ regulator·Î½á ÀÛ¿ëÇÏ¿© ILC2 response ¹× airway inflammation¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÔÀ» ±Ô¸íÇÏ¿´½À´Ï´Ù.
¶ÇÇÑ Ãµ½Ä ȯÀÚÀÇ Ç÷¾×¿¡¼­´Â Ang IIÀÇ ¼öÄ¡°¡ ³ô¾ÒÀ¸¸ç, ÀÌ´Â ILC2 ¿Íµµ correlationÀÌ ÀÖÀ½À» È®Àο´½À´Ï´Ù.
µû¶ó¼­ º» ³í¹®Àº ÀÌ·¯ÇÑ °á°úµéÀ» ÅëÇØ Ãµ½Ä Á¶Àý ¸ÞÄ¿´ÏÁò¿¡ ´ëÇÑ »õ·Î¿î ½Ã°¢À» Á¦½ÃÇÏ¿´½À´Ï´Ù.

º» ³í¹®À» ¼±Á¤ÇÑ ÀÌÀ¯´Â
ILC2¿Í ÁÖº¯ cellµé°úÀÇ interaction¿¡ ´ëÇØ °øºÎÇÏ°í , ÇöÀç ÁøÇàÇÏ°í ÀÖ´Â ÀúÀÇ ¿¬±¸¿¡ Âü°íÇÏ°íÀÚ ¼±Á¤ÇÏ¿´½À´Ï´Ù.

¿­½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.

°¨»çÇÕ´Ï´Ù.

Æò¿µÁø ¿Ã¸²


¹ßÇ¥³í¹®¸µÅ©: https://rupress.org/jem/article/219/3/e20211001/212967/Angiotensin-II-enhances-group-2-innate-lymphoid
÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
7/23 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä À̹øÁÖ Åä¿ä ¼¼¹Ì³ª ¹ßÇ¥ÀÚ ³ª·¡ÀÔ´Ï´Ù. Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÏ°Ô µÉ ³í¹®Àº Microbiology spectrum(IF:9.043)¿¡ ¿ÃÇØ 4¿ù¿¡ °ÔÀçµÈ "EGCG restricts PRRSV proliferation by disturbing lipid metabolism"À̶ó´Â Á¦¸ñÀÇ ³í¹®ÀÔ´Ï´Ù. ³ìÂ÷ ÃßÃâ¹°ÀÎ EGCG´Â Ç× ¹ÙÀÌ·¯½º È¿°ú°¡ ÀÖ´Ù°í ¾Ë..
ÀÌÀü±Û
7/16 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ °ü¸®ÀÚ
¾È³çÇϼ¼¿ä ö±Õ ÀÔ´Ï´Ù. À̹ø¿¡ ¹ßÇ¥µå¸± ³í¹®ÀÇ Á¦¸ñÀº "IFN-γ–dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis" À̸ç, Áö³­´Þ 8ÀÏ (2022.06.08), SCIENCE ADVACNES¿¡ ÃâÆÇµÈ ³í¹®ÀÔ´Ï´Ù. ¾ÏÀÇ..